Study confirms: drug prices higher in U.S

Article Abstract:

A General Accounting Office study showed that prescription drugs are far more expensive in the US than in Canada or other countries. The study, delivered to the House Energy and Commerce Committee health subcommittee, demonstrated that many drugs cost at least 50% less in Canada than in the US. Canadian drug prices are controlled by federal price limit regulations and the bargaining power of provincial governments who buy the drugs in bulk. A proposed Prescription Drug Prices Review Board Act of 1993 would establish a group to track and disseminate drug pricing data and recover government benefits from companies that overcharge for drugs.

Legislative bodies, Drugs, Prices and rates, Reports, Investigations, United States. Government Accountability Office, United States. Congress. House. Committee on Energy and Commerce

---

FDA, drug makers enter era of good feeling over user fees

Article Abstract:

The Food and Drug Administration (FDA) and the pharmaceutical industry are working to implement a program whereby pharmaceutical companies would pay a user's fee to the FDA to fund the salaries of FDA drug reviewers. Increasing the number of drug reviewers would speed up the approval process and save money for the pharmaceutical companies. The program, which will be put in place over five years, will eventually charge companies a one-time fee not more than $233,000. Firms with fewer than 500 employees will be charged half that amount. Six-month drug approval by 1997 is the goal for drugs to treat life-threatening diseases.

Regulation of agricultural marketing, Pharmaceutical industry, Finance, United States. Food and Drug Administration, Drug testing, Drug approval

---

Similar abstracts:

• Abstracts: Panel questions prices on government-backed drugs. Veterans groups urge expanded eligibility for VA care. Federal government criticized on lack of funding for TB
• Abstracts: Medicine, government talk cost control: White House proposes reform trade-off
• Abstracts: Medicine pauses at the price: split on cost control, doctors strive to prove they're ready for reform. Reform panic: doctors, hospitals rush to integrate services
• Abstracts: In antitrust relief fight, whose side are lawyers on? More states hold managed care accountable
• Abstracts: Touted vaccination plan hasn't appeared. Funds offered as first step in rebuilding vaccine plans

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.